TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8645833

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1-g dose)
Number of subjects: 784
Study: 2138532

Group type: EXPERIMENTAL
Intervention: GR 38032F (16 mg orally thrice daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: GR 38032F
Number of subjects: 39
Study: 6118250

Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg b.i.d. orally for 3 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ketotifen (7-day medication)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 29043507

Group type: EXPERIMENTAL
Intervention: Local infiltration anesthesia via pressure syringe (P-INF)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block anesthesia (IANB)
Number of subjects: 101
Study: 27636542

Group type: EXPERIMENTAL
Intervention: Synriam plus praziquantel
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Praziquantel
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Moxidectin
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Synriam
Number of subjects: 128
Study: 24476082

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) urinary hCG injection
Number of subjects: 22

Group type: COMPARATOR
Intervention: Subcutaneous (s.c.) recombinant hCG injection
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: hCG injection (both i.m. and s.c.)
Number of subjects: 22

Group type: COMPARATOR
Intervention: hCG injection (s.c.)
Number of subjects: 22
Study: 22289158

Group type: EXPERIMENTAL
Intervention: Consistent auditory cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inconsistent auditory cues
Number of subjects: 0
Study: 20385444

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Minimal intervention (reference material)
Number of subjects: 524
Study: 18684076

Group type: EXPERIMENTAL
Intervention: Japanese acupuncture treatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sham acupuncture treatment
Number of subjects: 7
Study: 15999118

Group type: EXPERIMENTAL
Intervention: 5 mg finasteride/day for 4 weeks prior to surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no finasteride treatment)
Number of subjects: 40
Study: 14600543

Group type: EXPERIMENTAL
Intervention: Vitamin E (50 mg.d(-1)) and beta-carotene (20 mg.d(-1)) in subjects with heavy exercise at leisure
Number of subjects: 14401

Group type: COMPARATOR
Intervention: Placebo in subjects with heavy exercise at leisure
Number of subjects: 14401

Group type: EXPERIMENTAL
Intervention: Physical activity at work and leisure
Number of subjects: 14401

Group type: EXPERIMENTAL
Intervention: Vitamin E and beta-carotene in subjects with physically load-bearing jobs
Number of subjects: 14401
Study: 11858450

Group type: EXPERIMENTAL
Intervention: APN care only
Number of subjects: 140

Group type: COMPARATOR
Intervention: No nursing care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Registered nurse (RN) care only
Number of subjects: 140

Group type: COMPARATOR
Intervention: Both RN and APN care
Number of subjects: 140
Study: 9109467

Group type: EXPERIMENTAL
Intervention: African-American men
Number of subjects: 332544

Group type: COMPARATOR
Intervention: White men
Number of subjects: 332544

Group type: COMPARATOR
Intervention: African-American men compared to white men
Number of subjects: 332544

Group type: EXPERIMENTAL
Intervention: Hypertensive ESRD
Number of subjects: 332544
Study: 1460451

Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg oral dose
Number of subjects: 22

Group type: COMPARATOR
Intervention: Terconazole 80 mg vaginal suppository daily for 3 days
Number of subjects: 22
Study: 3913875

Group type: EXPERIMENTAL
Intervention: mianserin
Number of subjects: 92

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 92
Study: 30295544

Group type: EXPERIMENTAL
Intervention: Snowflake MultiTeach (MT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diamond Touch Table (DTT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 32
Study: 29342844

Group type: EXPERIMENTAL
Intervention: Short vacation in a hotel outside usual environment (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vacation at home (control group, n = 20)
Number of subjects: 40
Study: 26823269

Group type: EXPERIMENTAL
Intervention: Structured intervention with written stepped-dose reduction (SIW)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Structured intervention with stepped-dose reduction and follow-up visits (SIF)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 532
Study: 24063257

Group type: EXPERIMENTAL
Intervention: Diet rich in kernel-based barley products, brown beans and chickpeas (D1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control diet (D2)
Number of subjects: 46
Study: 22934594

Group type: EXPERIMENTAL
Intervention: Endoscopic Papillary Large Balloon Dilation (EPLBD)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Endoscopic Sphincterotomy (ES)
Number of subjects: 83
Study: 21122660

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/20 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: simvastatin 40 mg
Number of subjects: 112
Study: 18285431

Group type: EXPERIMENTAL
Intervention: Community intervention (practice of functional gait activities in community environments)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hospital-based physiotherapy (Motor Relearning approach)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Community intervention
Number of subjects: 30
Study: 15923574

Group type: EXPERIMENTAL
Intervention: Elderly patients receiving any cancer treatment
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Elderly patients having a clinical trial discussion
Number of subjects: 1505
Study: 12917169

Group type: EXPERIMENTAL
Intervention: Digital stereoscopic fundus images
Number of subjects: 91

Group type: COMPARATOR
Intervention: 35‐mm film
Number of subjects: 91
Study: 12080674

Group type: EXPERIMENTAL
Intervention: Nao Yi-an (NYA) granule
Number of subjects: 38

Group type: COMPARATOR
Intervention: Western Medicine (WM)
Number of subjects: 38
Study: 8929750

Group type: EXPERIMENTAL
Intervention: Potassium diclofenac suspension (Flogan, Merck, 7ml, 105 mg) after food intake (FOOD phase)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Potassium diclofenac suspension (Flogan, Merck, 7ml, 105 mg) after gastric acid secretion blockade (OME phase)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo phase (PLA)
Number of subjects: 13
Study: 1754989

Group type: EXPERIMENTAL
Intervention: Evening dose of dexamethasone (11.00 p.m.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Morning dose of dexamethasone (08.00 a.m.)
Number of subjects: 6
Study: 6500633

Group type: EXPERIMENTAL
Intervention: Essential hypertension cases (n=33)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Normotensive control subjects (n=30)
Number of subjects: 33
Study: 31760207

Group type: EXPERIMENTAL
Intervention: Real cupping therapy (15 minutes, bilaterally at points BL23, BL24, BL25)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cupping therapy
Number of subjects: 0
Study: 30180279

Group type: EXPERIMENTAL
Intervention: Group cognitive‐existential intervention for fear of cancer recurrence (FCR)
Number of subjects: 106
Study: 25800460

Group type: EXPERIMENTAL
Intervention: Community singing program
Number of subjects: 131
Study: 26248442

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Masking Therapy (Control)
Number of subjects: 157
Study: 22364477

Group type: EXPERIMENTAL
Intervention: Theatre in education method (Group A, n = 42)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Simulated patients (Group B, n = 44)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Role-play (Group C, n = 43)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 129
Study: 20395225

Group type: EXPERIMENTAL
Intervention: Reporting suspected child maltreatment training
Number of subjects: 55

Group type: COMPARATOR
Intervention: Learning to be sensitive to ethnicity
Number of subjects: 55
Study: 22304889

Group type: EXPERIMENTAL
Intervention: CS only
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Contingent CS-US pairings
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Unpaired CS and US presentations
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Unpaired 'discrimination' contingency with exteroceptive discrimination cue
Number of subjects: 104
Study: 15943568

Group type: EXPERIMENTAL
Intervention: 600 mg hydroxyurea
Number of subjects: 115

Group type: COMPARATOR
Intervention: 800-900 mg hydroxyurea
Number of subjects: 115
Study: 12183784

Group type: EXPERIMENTAL
Intervention: Self-training (5 times/week for 15 minutes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiotherapist-supervised exercises (30 sessions on average)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-training
Number of subjects: 40
Study: 10485504

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg/d
Number of subjects: 251

Group type: COMPARATOR
Intervention: omeprazole 40 mg/d
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: lansoprazole 15 mg/d
Number of subjects: 251

Group type: COMPARATOR
Intervention: omeprazole 20 mg/d
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: lansoprazole 15 mg
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg
Number of subjects: 251

Group type: COMPARATOR
Intervention: omeprazole 20 mg
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: lansoprazole and omeprazole
Number of subjects: 251
Study: 8684201

Group type: EXPERIMENTAL
Intervention: Left dorsolateral prefrontal cortex rTMS
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 17

Group type: COMPARATOR
Intervention: Stimulation of different cortical areas
Number of subjects: 17
Study: 1929762

Group type: EXPERIMENTAL
Intervention: Desipramine hydrochloride substitution for 2 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clomipramine therapy (nonsubstituted group)
Number of subjects: 26
Study: 7037983

Group type: EXPERIMENTAL
Intervention: Live RSV vaccine
Number of subjects: 510

Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 510
Study: 30301662

Group type: EXPERIMENTAL
Intervention: Hypertonic saline alone (group HTS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypertonic saline and hydroxyethyl starch (HES) (group HTS/HES)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups (HTS and HTS/HES)
Number of subjects: 10
Study: 26613790

Group type: EXPERIMENTAL
Intervention: 200 μg chromium supplements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25752386

Group type: EXPERIMENTAL
Intervention: IG-IMRT
Number of subjects: 475

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 475
Study: 23703468

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii
Number of subjects: 181

Group type: COMPARATOR
Intervention: Nystatin
Number of subjects: 181
Study: 20578267

Group type: EXPERIMENTAL
Intervention: Theophylline 10(‐5) M
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 12
Study: 18804136

Group type: EXPERIMENTAL
Intervention: CL184 (20IU/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CL184 (20 or 40IU/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16084757

Group type: EXPERIMENTAL
Intervention: WebCT group (n=39)
Number of subjects: 85

Group type: COMPARATOR
Intervention: WWW group (n=46)
Number of subjects: 85
Study: 12970656

Group type: EXPERIMENTAL
Intervention: Twin-block appliance
Number of subjects: 174

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 174
Study: 10894101

Group type: EXPERIMENTAL
Intervention: Respocort (250-1000 microg per dose; cumulative dose 2000 microg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Becloforte (250-1000 microg per dose; cumulative dose 2000 microg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control mixture (containing surfactant and CFC propellants)
Number of subjects: 18
Study: 8927657

Group type: EXPERIMENTAL
Intervention: Risperidone-treated patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 12
Study: 2066844

Group type: EXPERIMENTAL
Intervention: Clindamycin (20 mg/kg per day, three times a day for 10 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Penicillin plus rifampin (benzathine penicillin intramuscularly and rifampin 20 mg/kg per day, twice a day for 4 days)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Clindamycin (including crossover patients)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Penicillin plus rifampin (including crossover patients)
Number of subjects: 55
Study: 7034680

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of gentamicin sulfate and clindamycin phosphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 0
Study: 30247401

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 240

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 240
Study: 26861051

Group type: EXPERIMENTAL
Intervention: Mesalamine granules (MG) 1.5 g once daily
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Mesalamine granules (MG)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Mesalamine granules (MG) and Placebo
Number of subjects: 562
Study: 25511452

Group type: EXPERIMENTAL
Intervention: Structured use of a pedometer and handbook with support from a practice nurse trained in behaviour change techniques (BCTs)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Structured use of a pedometer and handbook without support from a practice nurse trained in behaviour change techniques (BCTs)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Behaviour change techniques (BCTs) reported to have the most impact
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Rewards
Number of subjects: 43
Study: 23297520

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo controlled food challenge test
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Specific IgE and skin prick tests
Number of subjects: 179
Study: 20427960

Group type: EXPERIMENTAL
Intervention: Prevention strategies for cardiorenal syndromes, including identification and amelioration of precipitating factors, optimal management of chronic heart and kidney diseases, and multimodality therapies for end-organ protection.
Number of subjects: 0
Study: 18483650

Group type: EXPERIMENTAL
Intervention: School-based obesity prevention intervention including nutrition education and promotion of physical activity.
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Control group (similar school in Quillota).
Number of subjects: 1760

Group type: EXPERIMENTAL
Intervention: School-based obesity prevention intervention.
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 1760
Study: 15872223

Group type: EXPERIMENTAL
Intervention: Amplified enzyme immunoassay (EIA) with negative gray zone testing
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Cobas PCR
Number of subjects: 1003
Study: 11902268

Group type: EXPERIMENTAL
Intervention: HME changed every 24 hrs
Number of subjects: 155

Group type: COMPARATOR
Intervention: HME changed every 7 days
Number of subjects: 155
Study: 10511423

Group type: EXPERIMENTAL
Intervention: Scrambled-sentences task with illness terms
Number of subjects: 3355

Group type: COMPARATOR
Intervention: Scrambled-sentences task with neutral terms
Number of subjects: 3355

Group type: EXPERIMENTAL
Intervention: Estimates of likelihood of catastrophic illness
Number of subjects: 3355

Group type: EXPERIMENTAL
Intervention: Estimates of likelihood of minor illnesses
Number of subjects: 3355

Group type: EXPERIMENTAL
Intervention: Self-esteem
Number of subjects: 3355
Study: 7837862

Group type: EXPERIMENTAL
Intervention: Reduced-osmolarity ORS (224 mmol/L)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Standard ORS (311 mmol/L)
Number of subjects: 447
Study: 2351319

Group type: EXPERIMENTAL
Intervention: Cisplatin (100 mg/m2 iv bolus) and 5-fluorouracil (1000 mg/m2/day for 4 days) with allopurinol (900 mg orally, starting 5 days before 5-fluorouracil)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cisplatin and 5-fluorouracil without allopurinol
Number of subjects: 52
Study: 351827

Group type: EXPERIMENTAL
Intervention: Bovine (Kiel) bone interbody fusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autogenous bone interbody fusion
Number of subjects: 20
Study: 30188331

Group type: EXPERIMENTAL
Intervention: Equol producers
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Higher consumption of foods such as meat, fish, soy, vegetables, and Japanese snacks
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: High intake of Ramen and smoking
Number of subjects: 58
Study: 27957644

Group type: EXPERIMENTAL
Intervention: Blind bedside technique (BST)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Fluoroscopically guided technique (FGT)
Number of subjects: 180
Study: 26342674

Group type: EXPERIMENTAL
Intervention: Perioperative FOLFOX chemotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 82
Study: 22883712

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (dual treatment) for seven days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aspirin alone (monotherapy) for seven days
Number of subjects: 70
Study: 21872933

Group type: EXPERIMENTAL
Intervention: Early treatment (ET) - laser photocoagulation at high-risk prethreshold ROP
Number of subjects: 401

Group type: COMPARATOR
Intervention: Conventional management (CM) - treatment only if threshold ROP developed
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Both ET and CM
Number of subjects: 401
Study: 20076870

Group type: EXPERIMENTAL
Intervention: Hysterectomy and pelvic reconstruction floor with mesh (n=15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Hysteropexy and pelvic reconstruction floor with mesh (n=16)
Number of subjects: 31
Study: 17983937

Group type: EXPERIMENTAL
Intervention: Insulin sensitizers
Number of subjects: 0
Study: 15566709

Group type: EXPERIMENTAL
Intervention: Videotaped information regarding consent for surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: Verbal information regarding consent for surgery
Number of subjects: 48
Study: 11172346

Group type: EXPERIMENTAL
Intervention: PEG(40kd) IFN alpha‐2a 45 microg once weekly
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PEG(40kd) IFN alpha‐2a 90 microg once weekly
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PEG(40kd) IFN alpha‐2a 180 microg once weekly
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PEG(40kd) IFN alpha‐2a 270 microg once weekly
Number of subjects: 159

Group type: COMPARATOR
Intervention: IFN alpha‐2a 3 MIU 3 times weekly
Number of subjects: 159
Study: 9666761

Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg twice daily
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Oxybutynin 5 mg three times daily
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 7645930

Group type: EXPERIMENTAL
Intervention: Radioimmunoassisted follow-up plan (Group 1)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Traditional examinations (Group 2)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Immunoscintigraphy
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: RIGE
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: IORIL
Number of subjects: 485
Study: 2529059

Group type: EXPERIMENTAL
Intervention: Synthetic atrial natriuretic factor (ANF) at 1 pmol/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Synthetic atrial natriuretic factor (ANF) at 2 pmol/kg/min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (hemaccel)
Number of subjects: 8
Study: 794996

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel (0.5%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Commercial toothpaste with claimed chlorhexidine content
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional toothpastes (2 types)
Number of subjects: 10
Study: 31292906

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 28060534

Group type: EXPERIMENTAL
Intervention: Surgical repair of stable ramp lesions
Number of subjects: 91

Group type: COMPARATOR
Intervention: Abrasion and trephination of stable ramp lesions
Number of subjects: 91
Study: 25529005

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 78
Study: 23111547

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21796066

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg (single intravenous infusion)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Raloxifene 60 mg (daily oral for 6 months)
Number of subjects: 110
Study: 19250151

Group type: EXPERIMENTAL
Intervention: Statin Choice decision aid
Number of subjects: 98

Group type: COMPARATOR
Intervention: Patient pamphlet about dyslipidaemia
Number of subjects: 98
Study: 16717032

Group type: EXPERIMENTAL
Intervention: Ximelagatran (2 x 36 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Enoxaparin/warfarin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ximelagatran (2 x 24 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 12870820

Group type: EXPERIMENTAL
Intervention: Unimpaired speakers of Italian
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alzheimer's Disease (AD) patients
Number of subjects: 0
Study: 10836333

Group type: EXPERIMENTAL
Intervention: Nebulized recombinant human deoxyribonuclease (DNase)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 52
Study: 8943829

Group type: EXPERIMENTAL
Intervention: Diesel exhaust with the particle trap at the tail pipe
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unfiltered diesel exhaust
Number of subjects: 12

Group type: COMPARATOR
Intervention: Air
Number of subjects: 12